These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9164595)

  • 1. Effects of dopamine antagonists on changes in spontaneous EEG and locomotor activity in ketamine-treated rats.
    Yamamoto M; Mizuki Y; Suetsugi M; Ozawa Y; Ooyama M; Suzuki M
    Pharmacol Biochem Behav; 1997; 57(1-2):361-5. PubMed ID: 9164595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine.
    Matulewicz P; Kasicki S; Hunt MJ
    Brain Res; 2010 Dec; 1366():226-32. PubMed ID: 20888326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations.
    Anderson PM; Pinault D; O'Brien TJ; Jones NC
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1895-904. PubMed ID: 24964190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
    Ma J; Leung LS
    Psychopharmacology (Berl); 2007 May; 191(4):961-74. PubMed ID: 17219218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice.
    Irifune M; Shimizu T; Nomoto M
    Pharmacol Biochem Behav; 1991 Oct; 40(2):399-407. PubMed ID: 1805243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: Ketamine and lisdexamfetamine-induced hyperlocomotion in rats.
    Wendler E; de Souza CP; Vecchia DD; Kanazawa LKS; de Almeida Soares Hocayen P; Wöhr M; Schwarting RKW; Andreatini R
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1900-1908. PubMed ID: 27842942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A; Kulkarni SK; Nayar U
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
    Sharma AC; Thorat SN; Nayar U; Kulkarni SK
    Indian J Physiol Pharmacol; 1991 Apr; 35(2):111-6. PubMed ID: 1838740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multiple effects of ketamine on electroencephalographic activity and behavior in WAG/Rij rats.
    Midzyanovskaya IS; Salonin DV; Bosnyakova DY; Kuznetsova GD; van Luijtelaar EL
    Pharmacol Biochem Behav; 2004 Sep; 79(1):83-91. PubMed ID: 15388287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NMDA-receptor ligands on neocortical and hippocampal EEG activity of rat brain.
    Sharma AC; Kulkarni SK; Nayar U
    Indian J Exp Biol; 1991 Aug; 29(8):744-50. PubMed ID: 1837539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of remoxipride, a dopamine D-2 antagonist antipsychotic, on sleep-waking patterns and EEG activity in rats and rabbits.
    Ongini E; Bo P; Dionisotti S; Trampus M; Savoldi F
    Psychopharmacology (Berl); 1992; 107(2-3):236-42. PubMed ID: 1352054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of morphine on EEG in rats and their possible relations to hypo- and hyperkinesia.
    Ferger B; Kuschinsky K
    Psychopharmacology (Berl); 1995 Jan; 117(2):200-7. PubMed ID: 7753968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK; Weinberger DR
    Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cataleptic activity of the denatured venom of the social wasp Agelaia vicina (Hymenoptera, Vespidae) in Rattus norvegicus (Rodentia, Muridae).
    de Oliveira L; Cunha AO; Mortari MR; Coimbra NC; Dos Santos WF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):198-203. PubMed ID: 16310919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.
    Fujáková M; Páleníček T; Brunovský M; Gorman I; Tylš F; Kubešová A; Řípová D; Krajča V; Horáček J
    Pharmacol Biochem Behav; 2014 Jul; 122():212-21. PubMed ID: 24631484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.